Strengthening Priority Businesses Centered on Liquid Chromatographs and Mass Spectrometry Systems

「Specifically, we expanded our liquid chromatography and mass spectrometry systems to meet research and development, quality control and labor-saving needs in the pharmaceutical and food markets, while advancing the recurring business through measures such as strengthening the reagent and consumables lineup and expanding the service business.」

「Under the initiative to "strengthen priority businesses," we promoted the development of new products that use robotics and AI and improve operability, while seeking to provide total solutions covering customers' entire workflows in addition to further enhancing functions and specifications.」

「In the Measuring Instruments business, we strengthened sales in growth fields, including the pharmaceutical markets in other parts of Asia and the clinical testing market in North America. We also actively launched new products incorporating AI and robotics and improved operability, and worked to strengthen our ability to propose solutions.」

「The Company will also expand its solution offerings, including by entering the pharmaceutical purification equipment market.」

「Under the “strengthening priority businesses” initiative, the company is seeking to expand earnings by launching new products, including mass spectrometry systems offering high sensitivity, stability and ease of operation,」

「In the Life Science field, liquid chromatographs and mass spectrometry systems are positioned as priority products, mainly for the pharmaceutical and food markets. Under the concept of analytical transformation (AX: Analytical transformation), the Company supports customers' efficiency and labor savings by automating all analytical work, from sample preparation through data analysis, with AI and providing it as a total solution.」

「Against this backdrop, investment was strengthened in the healthcare field, particularly pharmaceuticals, where drug discovery research and domestic production are advancing globally, and in the green field, where initiatives addressing climate change are becoming more active. Sales of the priority products liquid chromatographs, mass spectrometry systems and gas chromatographs increased.」

「The Measuring Instruments business achieved revenue growth both in Japan and overseas. Liquid chromatographs and mass spectrometry systems increased in the healthcare field, gas chromatographs increased in the green field, and testing machines increased in the materials field. The results of 島津ダイアグノスティクス株式会社, which became a consolidated subsidiary last September, also contributed.」

「Overseas, sales of liquid chromatographs, mass spectrometry systems, and gas chromatographs increased in the healthcare, green, and academic fields. The performance of Shimadzu Diagnostics Corporation also contributed.」

「In the healthcare sector, we aim to provide total solutions centered on liquid chromatographs (LC) and mass spectrometry systems (MS). While strengthening the competitiveness of our core products, we will pursue greater efficiency through the automation of our customers’ entire analytical processes, the use of AI and integration with informatics, and will build a structure for providing the data they require.」

「The Measuring Instruments business was affected by the spread of the novel coronavirus in China and shortages of parts and materials. At the same time, global progress in drug discovery and the domestic production of pharmaceuticals increased demand for core liquid chromatographs in healthcare applications, particularly pharmaceuticals. In Japan, sales of novel coronavirus detection reagent kits increased as the number of infections rose, and the consolidation of 日水製薬株式会社 as a subsidiary also contributed to results.」

「As drug discovery and development and domestic pharmaceutical production advanced globally, demand for the core liquid chromatographs increased in the healthcare field, particularly pharmaceuticals, although the business was affected by China's lockdowns and shortages of components and materials.」

「The measuring instruments business performed well, with liquid chromatographs for pharmaceutical applications benefiting from increased investment in healthcare.」

「In the measuring instruments business, the Company is focusing on developing chromatographic analysis systems, mass spectrometry systems, optical analysis systems, life science-related analysis systems, and surface analysis and observation systems.」

「In healthcare, liquid chromatographs and mass spectrometry systems, the core products for pharmaceutical and contract analysis applications, performed well. New coronavirus detection reagent kits and fully automated PCR testing systems also contributed to results.」

「In healthcare and among government agencies and universities, core liquid chromatographs and mass spectrometry systems remained strong, while sales of novel coronavirus detection reagent kits and fully automated PCR testing systems also increased.」

「The company is expanding its product lineup, centered on liquid chromatographs and mass spectrometry systems in the measuring instruments business, to include high-resolution, high-sensitivity high-end products and fully automated sample-preparation systems using AI, IoT and robotics. It is also promoting practical implementation in society with strategic and business partners by combining these products with software that enables remote work.」

「At that time, the key products that support business growth were liquid chromatographs and mass spectrometry systems, which are among the company's strengths. The company will strengthen sales of these products worldwide and expand its recurring-revenue business to reinforce the foundation for sustainable business growth.」

「At that time, the key products that support business growth were liquid chromatographs and mass spectrometry systems, which are among the company's strengths. The company will strengthen sales of these products worldwide and expand its recurring-revenue business to reinforce the foundation for sustainable business growth.」

「At that time, the company explained that current business growth is supported by key products that are its strengths, such as liquid chromatographs and mass spectrometry systems. It will strengthen sales of these products worldwide while expanding the recurring business, thereby working to strengthen the foundation for sustainable business growth.」

「Using Group-wide resources centered on liquid chromatographs and mass spectrometry systems in the analytical and measuring instruments business, we aim to expand our product lineup and increase our market share in Europe and the United States. To this end, we will strengthen and leverage innovation centers worldwide, respond more quickly to customer and market needs, and create solutions combining data utilization and robotic automation.」